Veru Inc is trading at $3.15 (5% up) as it stages a technical rebound following sharp declines that followed its June 4 surge on a Novo Nordisk supply agreement.

  • The move appears to be a technical correction as traders reassess the stock's valuation after the recent rally and subsequent pullback.
  • There are no new company-specific headlines this morning, with investor focus remaining on the Novo Nordisk deal and improvements highlighted in the Q2 2026 earnings call.